Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori
- PMID: 28776748
- DOI: 10.1111/apt.14198
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori
Comment in
-
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori-authors' reply.Aliment Pharmacol Ther. 2017 Sep;46(5):551-552. doi: 10.1111/apt.14206. Aliment Pharmacol Ther. 2017. PMID: 28776746 No abstract available.
Comment on
-
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.Aliment Pharmacol Ther. 2017 Jul;46(2):106-114. doi: 10.1111/apt.14130. Epub 2017 May 12. Aliment Pharmacol Ther. 2017. PMID: 28497487
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources